Drugs / RAPA113
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04171687 | Oct 2019 → Feb 2020 | — | HK inno.N Corporation | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RAPA113 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04171687 ↗ |
| Route | Oral | “Oral administration of clopidogrel 75 mg tablet and RAPA113 tablet once daily for 7 days” NCT04171687 ↗ |